Status:
COMPLETED
Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Eligibility:
MALE
18-120 years
Brief Summary
RATIONALE: Collecting and storing samples of blood and urine from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarker...
Detailed Description
OBJECTIVES: Primary * Identify unique proteins or peptides that are associated with prostate cancer by comparing the proteomic or metabolomic analysis of serum, plasma, and urine from patients with ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Indication for a transrectal ultrasonography prostatic biopsy (as part of normal patient care) due to elevated prostate-specific antigen, or abnormal digital rectal examination, or surveillance for prostate cancer
- PATIENT CHARACTERISTICS:
- No prior or other concurrent malignancy except for curatively treated basal cell carcinoma of the skin
- No serious medical or psychiatric illness that would preclude informed consent
- No concurrent acute illness
- PRIOR CONCURRENT THERAPY:
- No participation in another clinical trial within the past 30 days
- No more than one enrollment into this study
Exclusion
Key Trial Info
Start Date :
February 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00373035
Start Date
February 1 2006
Last Update
January 19 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
SurroMed Incorporated
Menlo Park, California, United States, 94025
2
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States, 27157